191 related articles for article (PubMed ID: 36657719)
1. Investigation of Carcinogenic Impurities of N-Nitrosamines in Sartan Pharmaceutical Products Marketed in Brazil: Development and Validation of Method Based on High-Performance Liquid Chromatography-Tandem Mass Spectrometry.
Monteiro MA; de Lima PC; Novotny TS; Santana DS; Lima MED; Dantas ASCL; Ferreira LODS; de Souza MN; Maranho RLDN; Ochs SM
J Pharm Sci; 2023 May; 112(5):1305-1314. PubMed ID: 36657719
[TBL] [Abstract][Full Text] [Related]
2. A Multi-Analyte LC-MS/MS Method for Determination and Quantification of Six Nitrosamine Impurities in Sartans like Azilsartan, Valsartan, Telmisartan, Olmesartan, Losartan and Irbesartan.
Gopireddy RR; Maruthapillai A; Mahapatra S
J Chromatogr Sci; 2024 Feb; 62(2):147-167. PubMed ID: 35830866
[TBL] [Abstract][Full Text] [Related]
3. Rapid Quantitation of Four Nitrosamine Impurities in Angiotensin Receptor Blocker Drug Substances.
Zhang J; Selaya SD; Shakleya D; Mohammad A; Faustino PJ
J Pharm Sci; 2023 May; 112(5):1246-1254. PubMed ID: 36509171
[TBL] [Abstract][Full Text] [Related]
4. Thymol-Based Hydrophobic Deep Eutectic Solvents as a Green Approach for Screening Polar Nitrosamines in Sartans Pharmaceutical Products by Ultrasound-Assisted Dispersive Liquid-Liquid Microextraction Combined with HPLC-DAD.
Novotny TS; Monteiro MA; de Lima PC; Ochs SM; Maranho RLDN; Vaz FAS; Marques FFC
J Pharm Sci; 2023 May; 112(5):1231-1245. PubMed ID: 36481416
[TBL] [Abstract][Full Text] [Related]
5. LC-MS/MS Investigation of nitrosamine impurities in certain Sartan group medicinal products available in Istanbul, Türkiye.
Öncü T; Yüksel B; Binay E; Şen N
Ann Pharm Fr; 2024 Jan; 82(1):72-83. PubMed ID: 37567559
[TBL] [Abstract][Full Text] [Related]
6. Development of a sensitive LC-APCI-MS/MS method for simultaneous determination of eleven nitrosamines in valsartan and irbesartan with a simple extraction approach.
Mavis ME; Goksu Gursu G; Ular Cagatay N
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Feb; 1216():123593. PubMed ID: 36669257
[TBL] [Abstract][Full Text] [Related]
7. The contamination of valsartan and other sartans, part 1: New findings.
Sörgel F; Kinzig M; Abdel-Tawab M; Bidmon C; Schreiber A; Ermel S; Wohlfart J; Besa A; Scherf-Clavel O; Holzgrabe U
J Pharm Biomed Anal; 2019 Aug; 172():395-405. PubMed ID: 31122801
[TBL] [Abstract][Full Text] [Related]
8. Development of GC-MS/MS Method for Simultaneous Estimation of Four Nitrosoamine Genotoxic Impurities in Valsartan.
Tummala SR; Amgoth KP
Turk J Pharm Sci; 2022 Aug; 19(4):455-461. PubMed ID: 36047600
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous detection of nitrosamines and other sartan-related impurities in active pharmaceutical ingredients by supercritical fluid chromatography.
Schmidtsdorff S; Schmidt AH
J Pharm Biomed Anal; 2019 Sep; 174():151-160. PubMed ID: 31174128
[TBL] [Abstract][Full Text] [Related]
10. The contamination of valsartan and other sartans, Part 2: Untargeted screening reveals contamination with amides additionally to known nitrosamine impurities.
Scherf-Clavel O; Kinzig M; Besa A; Schreiber A; Bidmon C; Abdel-Tawab M; Wohlfart J; Sörgel F; Holzgrabe U
J Pharm Biomed Anal; 2019 Aug; 172():278-284. PubMed ID: 31078064
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of low molecular weight nitrosamines in pharmaceutical products by fast gas chromatography mass spectrometry.
Kalauz A; Tiringer KV; Horváth V; Kapui I
J Chromatogr A; 2023 Oct; 1708():464323. PubMed ID: 37696123
[TBL] [Abstract][Full Text] [Related]
12. Method for trace determination of N-nitrosamines impurities in metronidazole benzoate using high-performance liquid chromatography coupled with atmospheric-pressure chemical ionization tandem mass spectrometry.
Yin M; Hu Y; Fan H; Wang Q; Wang M; Wang W; Shi C
J Sep Sci; 2023 Mar; 46(5):e2200225. PubMed ID: 36562102
[TBL] [Abstract][Full Text] [Related]
13. Determination of Genotoxic Impurity
Xie B; Guo D; Mai B; Fan J
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364326
[No Abstract] [Full Text] [Related]
14. Determination of N-nitrosodimethylamine and N-nitrosomethylethylamine in drug substances and products of sartans, metformin and ranitidine by precipitation and solid phase extraction and gas chromatography-tandem mass spectrometry.
Lim HH; Oh YS; Shin HS
J Pharm Biomed Anal; 2020 Sep; 189():113460. PubMed ID: 32663759
[TBL] [Abstract][Full Text] [Related]
15. A GC-MS/MS Method for Trace Level Quantification of Six Nitrosamine Impurities (NDMA, NDEA, NEIPA, NDIPA, NDPA, and NDBA) in Commercially Used Organic Solvents: Dichloromethane, Ethyl Acetate, Toluene, and O-xylene.
Kosuri ER; Bhanti M; Jaywant MA; Han M; Wang X; Obeng M
J Pharm Sci; 2023 May; 112(5):1225-1230. PubMed ID: 36462706
[TBL] [Abstract][Full Text] [Related]
16. An Analytical Method for Determining N-Nitrosodimethylamine and N-Nitrosodiethylamine Contamination in Irbesartan, Olmesartan and Metformin by UPLC-APCI-MS/MS in Tablet Dosage Form.
Deeb AA; Hailat M; Aldoqum HM; Abuothman M; Abuyaman O; Abu Dayyih W
J Chromatogr Sci; 2024 Apr; 62(4):372-379. PubMed ID: 37622601
[TBL] [Abstract][Full Text] [Related]
17. Analysis of genotoxic N-nitrosamines in active pharmaceutical ingredients and market authorized products in low abundance by means of liquid chromatography - tandem mass spectrometry.
Vogel M; Norwig J
J Pharm Biomed Anal; 2022 Sep; 219():114910. PubMed ID: 35779354
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of four Nitrosamine Impurities Determination Method in Medicines of Valsartan, Losartan, and Irbesartan with HPLC-MS/MS (APCI).
Khorolskiy M; Ramenskaya G; Vlasov A; Perederyaev O; Maslennikova N
Iran J Pharm Res; 2021; 20(3):541-552. PubMed ID: 34904007
[TBL] [Abstract][Full Text] [Related]
19. Sartan blood pressure regulators in classical and biofilm wastewater treatment - Concentrations and metabolism.
Li R; Liang C; Svendsen SB; Kisielius V; Bester K
Water Res; 2023 Feb; 229():119352. PubMed ID: 36450176
[TBL] [Abstract][Full Text] [Related]
20. Nitrosamine Impurities in Pharmaceuticals: An Empirical Review of their Detection, Mechanisms, and Regulatory Approaches.
Bhirud D; Agrawal G; Shah H; Patel A; Palkar MB; Bhattacharya S; Prajapati BG
Curr Top Med Chem; 2024; 24(6):503-522. PubMed ID: 38321910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
